Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
- PMID: 6256552
- DOI: 10.1021/jm00186a029
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
Abstract
The crystal structures of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-nitrophenyl)-1,4-dihydropyridine (Nifedipine) and the 3-cyano-, 4-(dimethylamino)- and 2,3,4,5,6-pentafluorophenyl derivatives were determined. The 1,4-dihydropyridine ring in all four compounds has a boat-type conformation with varying degrees of puckering at the C4 position. Increasing distortion from planarity at this position shows a limited correlation with decreasing biological activity, determined as the ability to inhibit the Ca2+-dependent muscarinic-induced mechanical responses of guinea pig ileal longitudinal smooth muscle.
Similar articles
-
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.J Med Chem. 1982 Feb;25(2):126-31. doi: 10.1021/jm00344a007. J Med Chem. 1982. PMID: 7057416
-
Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.Drug Des Deliv. 1988 Nov;3(3):245-56. Drug Des Deliv. 1988. PMID: 2855579
-
Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.Drug Des Deliv. 1988 Feb;2(3):177-89. Drug Des Deliv. 1988. PMID: 2855573
-
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.J Med Chem. 1988 Feb;31(2):300-5. doi: 10.1021/jm00397a005. J Med Chem. 1988. PMID: 3339603
-
Slow channel calcium activators, a new group of pharmacological agents.Life Sci. 1985 Oct 7;37(14):1271-8. doi: 10.1016/0024-3205(85)90241-3. Life Sci. 1985. PMID: 2413326 Review.
Cited by
-
1,1'-[4-(2,4-Dichloro-phen-yl)-2,6-di-methyl-1,4-di-hydro-pyridine-3,5-di-yl]diethanone.Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 15;67(Pt 2):o380-1. doi: 10.1107/S1600536810052839. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21523057 Free PMC article.
-
Comparative molecular modelling study of the calcium channel blockers nifedipine and black mamba toxin FS2.J Comput Aided Mol Des. 1997 Sep;11(5):491-501. doi: 10.1023/a:1007974124426. J Comput Aided Mol Des. 1997. PMID: 9385552
-
Diethyl 4-[4-(dimethyl-amino)phen-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 6;66(Pt 3):o519. doi: 10.1107/S1600536810003508. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21580293 Free PMC article.
-
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.J Comput Aided Mol Des. 1991 Apr;5(2):95-106. doi: 10.1007/BF00129749. J Comput Aided Mol Des. 1991. PMID: 1651370
-
A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.Biochem J. 1988 Jul 1;253(1):49-58. doi: 10.1042/bj2530049. Biochem J. 1988. PMID: 3421952 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous